Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Acquired by Fuller & Thaler Asset Management Inc.

Fuller & Thaler Asset Management Inc. lifted its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) by 2.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,633,246 shares of the medical instruments supplier's stock after buying an additional 36,489 shares during the period. Fuller & Thaler Asset Management Inc. owned approximately 2.80% of Merit Medical Systems worth $157,968,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in MMSI. NewSquare Capital LLC purchased a new position in Merit Medical Systems during the 4th quarter worth $32,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Merit Medical Systems during the fourth quarter worth about $52,000. Federated Hermes Inc. increased its position in Merit Medical Systems by 139.1% in the 4th quarter. Federated Hermes Inc. now owns 655 shares of the medical instruments supplier's stock valued at $63,000 after acquiring an additional 381 shares during the period. Smartleaf Asset Management LLC raised its stake in Merit Medical Systems by 237.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,388 shares of the medical instruments supplier's stock valued at $134,000 after acquiring an additional 977 shares during the last quarter. Finally, GAMMA Investing LLC lifted its position in Merit Medical Systems by 14.7% during the 4th quarter. GAMMA Investing LLC now owns 1,494 shares of the medical instruments supplier's stock worth $144,000 after acquiring an additional 191 shares during the period. Institutional investors and hedge funds own 99.66% of the company's stock.

Insider Activity

In other news, CEO Fred P. Lampropoulos sold 31,320 shares of Merit Medical Systems stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $103.86, for a total value of $3,252,895.20. Following the completion of the transaction, the chief executive officer now directly owns 1,086,028 shares of the company's stock, valued at approximately $112,794,868.08. The trade was a 2.80 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Stephen C. Evans sold 5,000 shares of the business's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $105.31, for a total transaction of $526,550.00. Following the transaction, the director now directly owns 4,657 shares of the company's stock, valued at approximately $490,428.67. This trade represents a 51.78 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 109,132 shares of company stock worth $11,139,521 over the last 90 days. Company insiders own 3.70% of the company's stock.

Analysts Set New Price Targets

MMSI has been the topic of several recent analyst reports. Raymond James dropped their target price on Merit Medical Systems from $116.00 to $108.00 and set an "outperform" rating on the stock in a research report on Friday. Piper Sandler dropped their price target on Merit Medical Systems from $116.00 to $112.00 and set an "overweight" rating for the company in a research report on Wednesday. Needham & Company LLC decreased their target price on shares of Merit Medical Systems from $116.00 to $100.00 and set a "buy" rating on the stock in a research report on Friday. Wells Fargo & Company cut their price target on Merit Medical Systems from $120.00 to $117.00 and set an "overweight" rating for the company in a report on Wednesday, February 26th. Finally, Barrington Research lowered their price objective on Merit Medical Systems from $111.00 to $103.00 and set an "outperform" rating for the company in a research report on Friday. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Merit Medical Systems currently has an average rating of "Moderate Buy" and an average target price of $109.00.

Merit Medical Systems Trading Down 0.1 %

Shares of NASDAQ MMSI traded down $0.06 during midday trading on Friday, hitting $94.61. The stock had a trading volume of 1,278,090 shares, compared to its average volume of 497,068. The company has a fifty day moving average price of $98.60 and a 200 day moving average price of $100.52. The company has a market capitalization of $5.59 billion, a price-to-earnings ratio of 46.38, a PEG ratio of 2.34 and a beta of 0.85. Merit Medical Systems, Inc. has a 1-year low of $73.40 and a 1-year high of $111.45. The company has a quick ratio of 3.82, a current ratio of 5.36 and a debt-to-equity ratio of 0.57.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.